Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
The purpose of this study is to help scientists and clinicians discover answers to research questions related to antibiotic-resistant bacterial infections, and the role that phage therapy plays as a possible treatment.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Enrollment of study participants | To recruit and enroll participants up to 100 participants who have received or will receive phage therapy treatment | 5 years |
| Collection of biospecimens | Total number of biospecimens collected which may include blood samples and synovial fluid | 5 years |
| Medical record review | Review the medical record of enrolled participants to ascertain any new health outcomes. | 5 years |
| Increase treatment options and level of care for patients with bacterial infections | Total number of collaborations with clinical investigators and researchers at both Mayo Clinic and across the globe. | 5 years |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Mayo Clinic patients receiving bacteriophage therapy.
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Gina Suh, MD | Mayo Clinic | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Mayo Clinic Rochester | Rochester | Minnesota | 55905 | United States |
Not provided
| Label | URL |
|---|---|
| Mayo Clinic Clinical Trials | View source |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
whole blood and synovial fluid will be stored in the biorepository for future research.